Who Owns Cogent Biosciences Stock?
NASDAQ: COGTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 115.22%
- Institutions (% of float)
- 115.71%
- Held by insiders
- 0.42%
- Institutional holders
- 438
- Institutions 99.6%
- Insiders 0.4%
- Public and other 0.0%
Who owns Cogent Biosciences stock?
Institutional investors own about 115.2% of Cogent Biosciences's shares, spread across 438 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.42% of COGT.
The largest institutional holders are FMR, LLC (14.80%), Blackrock Inc. (10.00%) and Vanguard Portfolio Management LLC (4.65%). Together, the top 10 institutions control 53.1% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their COGT positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of COGT
| Institution | Shares | % Held | Change |
|---|---|---|---|
| FMR, LLC | 25.68M | 14.80% | +11.1% |
| Blackrock Inc. | 17.35M | 10.00% | +8.2% |
| Vanguard Portfolio Management LLC | 8.07M | 4.65% | +10.1% |
| Vanguard Capital Management LLC | 7.41M | 4.27% | +7.5% |
| State Street Corporation | 6.96M | 4.01% | +23.0% |
| Jupiter Topco LLC | 6.62M | 3.82% | +100.0% |
| Fairmount Funds Management LLC | 5.50M | 3.17% | 0.0% |
| Deerfield Management Company, L.P | 5.01M | 2.88% | -44.6% |
| TCG Crossover Management, LLC | 4.85M | 2.80% | -1.9% |
| Price (T.Rowe) Associates Inc | 4.65M | 2.68% | +44.8% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of COGT
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 5.16M | 2.97% |
| iShares Trust-iShares Russell 2000 ETF | 4.25M | 2.45% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 3.72M | 2.15% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 3.34M | 1.93% |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 2.51M | 1.45% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund | 2.36M | 1.36% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.96M | 1.13% |
| Fidelity Securities Fund-Fidelity OTC Portfolio | 1.87M | 1.08% |
| Fidelity Select Portfolios-Select Health Care Portfolio | 1.85M | 1.07% |
| Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund | 1.83M | 1.06% |
Frequently asked questions
Who is the largest shareholder of Cogent Biosciences?
FMR, LLC is the largest institutional shareholder of COGT, owning 14.80% of shares outstanding (25.68M shares) as of its latest 13F filing.
What percentage of Cogent Biosciences is owned by institutions?
Institutions own about 115.2% of COGT shares and 115.7% of the public float.
How much of Cogent Biosciences do insiders own?
Insiders, such as officers and directors, own about 0.42% of COGT shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.